What's the Buzz About Hydroxynorketamine? Is It the History, the Story, the Debate, or the Promise?
Biol Psychiatry
.
2017 Apr 15;81(8):e61-e63.
doi: 10.1016/j.biopsych.2017.01.002.
Author
Chadi G Abdallah
1
Affiliation
1
Clinical Neurosciences Division, National Center for PTSD, US Department of Veterans Affairs, West Haven; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Electronic address: chadi.abdallah@yale.edu.
PMID:
28317551
PMCID:
PMC5484143
DOI:
10.1016/j.biopsych.2017.01.002
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Comment
Grants and funding
K23 MH101498/MH/NIMH NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States